ATE194921T1 - Verfahren zur inaktivierung von viren - Google Patents
Verfahren zur inaktivierung von virenInfo
- Publication number
- ATE194921T1 ATE194921T1 AT93907173T AT93907173T ATE194921T1 AT E194921 T1 ATE194921 T1 AT E194921T1 AT 93907173 T AT93907173 T AT 93907173T AT 93907173 T AT93907173 T AT 93907173T AT E194921 T1 ATE194921 T1 AT E194921T1
- Authority
- AT
- Austria
- Prior art keywords
- inactivation
- viruses
- supercritical
- directed
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84451392A | 1992-03-02 | 1992-03-02 | |
PCT/US1993/001916 WO1993017724A1 (en) | 1992-03-02 | 1993-03-02 | Viral inactivation method |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE194921T1 true ATE194921T1 (de) | 2000-08-15 |
Family
ID=25292924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93907173T ATE194921T1 (de) | 1992-03-02 | 1993-03-02 | Verfahren zur inaktivierung von viren |
Country Status (6)
Country | Link |
---|---|
US (2) | US5877005A (de) |
EP (1) | EP0629135B1 (de) |
JP (1) | JP4260877B2 (de) |
AT (1) | ATE194921T1 (de) |
DE (1) | DE69329108T2 (de) |
WO (1) | WO1993017724A1 (de) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017724A1 (en) * | 1992-03-02 | 1993-09-16 | Bioeng, Inc. | Viral inactivation method |
FR2699408B1 (fr) | 1992-12-21 | 1995-03-24 | Bioland | Procédé de traitement de tissus osseux et biomatériaux implantables correspondants. |
US5723012A (en) * | 1993-12-09 | 1998-03-03 | Bioland | Uses for a current of supercritical carbon dioxide as an antiviral agent |
FR2735372B1 (fr) * | 1995-06-13 | 1997-09-05 | Bioland | Nouvelles utilisations d'un courant de dioxyde de carbone supercritique a titre d'agent antiviral |
AUPN030794A0 (en) | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
US6149864A (en) * | 1998-06-25 | 2000-11-21 | Massachusetts Institute Of Technology | Supercritical fluid sterilization method |
AU752509B2 (en) * | 1999-12-27 | 2002-09-19 | Kabushiki Kaisha Sr Kaihatsu | Method and device for disinfection/sterilization of medical instruments |
AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
US20090017069A1 (en) * | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
US7407662B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified viral particles with immunogenic properties and reduced lipid content |
US7439052B2 (en) * | 2000-06-29 | 2008-10-21 | Lipid Sciences | Method of making modified immunodeficiency virus particles |
US7407663B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified immunodeficiency virus particles |
WO2003000372A2 (en) * | 2001-06-25 | 2003-01-03 | Lipid Sciences, Inc. | Systems and methods using multiple solvents for the removal of lipids from fluids |
US6991727B2 (en) * | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
US20030127386A1 (en) * | 2001-06-25 | 2003-07-10 | Bomberger David C. | Hollow fiber contactor systems for removal of lipids from fluids |
US20060060520A1 (en) * | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
EP1412045A4 (de) * | 2001-06-25 | 2007-05-02 | Lipid Sciences Inc | Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren |
US7033813B2 (en) * | 2001-09-05 | 2006-04-25 | Trevor P Castor | Inactivated vaccines for aids and other infectious diseases |
US20050053678A1 (en) * | 2001-10-03 | 2005-03-10 | Gow Robert T. | Methods and compositions for betel nut chewing gum |
US7001620B2 (en) | 2001-10-03 | 2006-02-21 | Herbal Science, Llc | Kavalactone product |
US7291352B2 (en) | 2001-10-03 | 2007-11-06 | Herbalscience Llc | Methods and compositions for oral delivery of Areca and mate' or theobromine |
US7037524B2 (en) * | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
US7029707B2 (en) * | 2001-10-03 | 2006-04-18 | Herbalscience, Llc | Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
US20050069596A1 (en) * | 2001-10-03 | 2005-03-31 | Gow Robert T. | Compositions and methods comprising kava and anti-anxiety compounds |
US7105185B2 (en) | 2001-10-03 | 2006-09-12 | Herbalscience, Llc | Kavalactone profile |
US7008591B2 (en) * | 2001-10-17 | 2006-03-07 | Edwards Lifesciences Corporation | Supercritical fluid extraction process for tissue preparation |
AU2003268190B2 (en) * | 2002-08-26 | 2008-04-03 | Eli Lilly And Company | Treating Alzheimers using delipidated protein particles |
US20050037025A1 (en) * | 2002-10-03 | 2005-02-17 | Gow Robert T. | Methods and compositions comprising kava and mate' or theobromine |
US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
CA2531227A1 (en) | 2003-07-03 | 2005-02-10 | Lipid Sciences Inc. | Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
US6960803B2 (en) * | 2003-10-23 | 2005-11-01 | Silicon Storage Technology, Inc. | Landing pad for use as a contact to a conductive spacer |
US7294353B2 (en) * | 2003-10-24 | 2007-11-13 | Herbalscience, Llc | Methods and compositions comprising ilex |
US7279184B2 (en) * | 2003-10-24 | 2007-10-09 | Herbalscience, Llc | Methods and compositions comprising Ilex |
US8734525B2 (en) * | 2003-12-31 | 2014-05-27 | Warsaw Orthopedic, Inc. | Osteoinductive demineralized cancellous bone |
US20070231788A1 (en) * | 2003-12-31 | 2007-10-04 | Keyvan Behnam | Method for In Vitro Assay of Demineralized Bone Matrix |
US8328876B2 (en) * | 2003-12-31 | 2012-12-11 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US7387749B2 (en) * | 2004-02-20 | 2008-06-17 | Wayne State University | Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid |
TWI302944B (en) * | 2004-07-12 | 2008-11-11 | Method for removing virus activity from biological materials | |
CN1318581C (zh) * | 2004-07-13 | 2007-05-30 | 南玮实业股份有限公司 | 利用超临界流体去除冠状病毒活性的方法 |
US20060269928A1 (en) * | 2005-05-27 | 2006-11-30 | Aphios Corporation | Compositions, methods and apparatus for supercritical fluid virus inactivation |
EP1942960B1 (de) * | 2005-11-01 | 2012-08-29 | Warsaw Orthopedic, Inc. | Verfahren zur herstellung von knochenmatrix-zusammensetzungen |
KR20080005678A (ko) * | 2006-07-10 | 2008-01-15 | 삼성전자주식회사 | 인쇄회로기판 및 이를 갖는 전자장치 |
US9554920B2 (en) | 2007-06-15 | 2017-01-31 | Warsaw Orthopedic, Inc. | Bone matrix compositions having nanoscale textured surfaces |
CA3062443C (en) * | 2007-06-15 | 2022-03-15 | Warsaw Orthopedic, Inc. | Method of treating tissue |
EP3207948B1 (de) * | 2007-06-15 | 2020-02-26 | Warsaw Orthopedic, Inc. | Knochenmatrixzusammensetzungen und verfahren |
US20110054408A1 (en) * | 2007-07-10 | 2011-03-03 | Guobao Wei | Delivery systems, devices, tools, and methods of use |
WO2009009688A1 (en) | 2007-07-10 | 2009-01-15 | Osteotech, Inc. | Delivery system |
CA2694854C (en) | 2007-08-17 | 2016-09-27 | Csl Behring Gmbh | Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
ES2446544T3 (es) | 2007-10-19 | 2014-03-10 | Warsaw Orthopedic, Inc. | Composiciones de matrices óseas desmineralizadas y métodos |
US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US9101475B2 (en) * | 2009-02-12 | 2015-08-11 | Warsaw Orthopedic, Inc. | Segmented delivery system |
WO2010148117A1 (en) | 2009-06-17 | 2010-12-23 | Scantibodies Laboratory, Inc. | Therapeutic and diagnostic affinity purified specific polyclonal antibodies |
US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
US20120302499A1 (en) | 2011-05-27 | 2012-11-29 | Matheny Robert G | Sterilized, acellular extracellular matrix compositions and methods of making thereof |
US8956566B2 (en) | 2012-03-12 | 2015-02-17 | Pure Biosolutions, Llc | System and method for virus inactivation |
EP2867359B1 (de) | 2012-06-29 | 2021-09-15 | EMD Millipore Corporation | Verfahren zur deaktivierung von viren während eines proteinaufreinigungsverfahren |
US8791054B2 (en) * | 2012-09-27 | 2014-07-29 | Halliburton Energy Services, Inc. | Methods of converting an inactive biocide into an active biocide using a chemical reaction |
KR102465762B1 (ko) * | 2014-10-24 | 2022-11-09 | 젠자임 코포레이션 | 멸균 공정 용기로부터의 유체 스트림에 대한 통합형 연속식 단리 |
EP3088006A1 (de) * | 2015-04-28 | 2016-11-02 | Bayer Technology Services GmbH | Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor |
JP2018082987A (ja) * | 2016-11-25 | 2018-05-31 | 株式会社日立製作所 | ウイルス不活化方法及びウイルス不活化装置 |
AU2018372198A1 (en) | 2017-11-22 | 2020-06-11 | Hdl Therapeutics, Inc. | Systems and methods for priming fluid circuits of a plasma processing system |
JP2021509894A (ja) | 2017-12-28 | 2021-04-08 | エイチディーエル セラピューティクス インコーポレイテッドHdl Therapeutics, Inc. | ヒト血漿から抽出されたpre−β高密度リポタンパク質を保存および投与するための方法 |
RU2691983C1 (ru) * | 2018-02-27 | 2019-06-19 | Общество с ограниченной ответственностью "Матрифлекс" | Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида |
TWI724396B (zh) * | 2018-03-30 | 2021-04-11 | 日商旭化成醫療股份有限公司 | 血液淨化器及其製法 |
EP4028511A1 (de) * | 2019-09-09 | 2022-07-20 | Valneva Austria GmbH | Inaktivierungsverfahren für viren |
WO2023063933A1 (en) * | 2020-10-12 | 2023-04-20 | Castor Trevor P | Apparatus and method for inactivating viruses and pathogens in human plasma units |
WO2022109430A1 (en) * | 2020-11-22 | 2022-05-27 | Castor Trevor P | Sustained release inactivated vaccines |
WO2023063932A1 (en) * | 2021-10-12 | 2023-04-20 | Castor Trevor P | Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32695E (en) * | 1979-04-12 | 1988-06-14 | Dasi Industries, Inc. | Method and apparatus for treating fluent materials |
US4615886A (en) * | 1983-08-31 | 1986-10-07 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus |
US4749522A (en) * | 1985-10-31 | 1988-06-07 | Angio-Medical Corporation | Supercritical fluid extraction of animal derived materials |
WO1991001367A1 (en) * | 1989-07-20 | 1991-02-07 | Bioeng, Inc. | Supercritical fluid disruption of and extraction from microbial cells |
WO1993017724A1 (en) * | 1992-03-02 | 1993-09-16 | Bioeng, Inc. | Viral inactivation method |
US5667835A (en) * | 1993-10-27 | 1997-09-16 | Nippan Tansan Co., Ltd. | Method for inactivating enzymes, microorganisms and spores in a liquid foodstuff |
US5520943A (en) * | 1993-10-27 | 1996-05-28 | Nippon Tansan Co., Ltd. | Method for modifying the quality of liquid foodstuff |
-
1993
- 1993-03-02 WO PCT/US1993/001916 patent/WO1993017724A1/en active IP Right Grant
- 1993-03-02 AT AT93907173T patent/ATE194921T1/de not_active IP Right Cessation
- 1993-03-02 EP EP93907173A patent/EP0629135B1/de not_active Expired - Lifetime
- 1993-03-02 JP JP51586093A patent/JP4260877B2/ja not_active Expired - Lifetime
- 1993-03-02 DE DE69329108T patent/DE69329108T2/de not_active Expired - Fee Related
-
1995
- 1995-10-25 US US08/547,851 patent/US5877005A/en not_active Expired - Lifetime
-
1999
- 1999-12-29 US US09/474,475 patent/US6465168B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69329108T2 (de) | 2001-03-22 |
JPH07505071A (ja) | 1995-06-08 |
JP4260877B2 (ja) | 2009-04-30 |
DE69329108D1 (de) | 2000-08-31 |
EP0629135A1 (de) | 1994-12-21 |
US5877005A (en) | 1999-03-02 |
US6465168B1 (en) | 2002-10-15 |
EP0629135B1 (de) | 2000-07-26 |
WO1993017724A1 (en) | 1993-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE194921T1 (de) | Verfahren zur inaktivierung von viren | |
DE68921948D1 (de) | System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien. | |
ATE80803T1 (de) | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. | |
DE69635871D1 (de) | Verfahren und Zusammensetzungen zur selektiven Modikation von Nukleinsäuren | |
DE69030596D1 (de) | Verfahren und Vorrichtung zur Behandlung von Proben | |
DE3874837D1 (de) | Verfahren und vorrichtung zur gassterilisation von erzeugnissen mit lumen. | |
DE69132098D1 (de) | Verfahren zur amplifikation von nukleinsäuren | |
ATE73351T1 (de) | Verfahren zur sterilisation von plasma oder plasmafraktionen. | |
DE3888205D1 (de) | Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. | |
ATE138575T1 (de) | Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen | |
DE69528475D1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
DE69829625D1 (de) | Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff | |
DE69525473D1 (de) | Vorrichtung zur behandlung von blutgefässen | |
ATE88097T1 (de) | Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut. | |
DE3781535D1 (de) | Verfahren und vorrichtung zur aseptischen behandlung von lebensmitteln. | |
DE69941157D1 (de) | Verfahren und vorrichtung zur behandlung von blutplasma oder blutplasmakonzentrat | |
DE3788749D1 (de) | Verfahren und Vorrichtung zur Feststellung von molekularen und ionischen Spezies. | |
PT79117B (de) | Verfahren zur pasteurisierung von humanplasma | |
DE68910928D1 (de) | Verfahren und Vorrichtung zur zentrifugalen Behandlung von Flüssigkeiten. | |
DE59309217D1 (de) | Verfahren zur Aktivierung von Blutgerinnungsfaktoren | |
ATE49185T1 (de) | Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung. | |
DE3775426D1 (de) | Verfahren zur behandlung von gasoelen. | |
DE69014501D1 (de) | Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück. | |
ATA134593A (de) | Verfahren und vorrichtung zur nachbehandlung von gebeizten stahlprodukten, insbesondere von gebeiztem c-stahl-warmband | |
DE59002951D1 (de) | Verfahren und vorrichtung zur vakuumbehandlung von metallen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |